Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more

Navigating Internal Constraints and Uncertainty

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, outlines the internal constraints that CFOs are reporting as their biggest manufacturing obstacle, along with other hurdles they are encountering.

How Health Plans Can Support Communities During Natural Disasters

When disasters occur, organizations such as SCAN Health Plan take a holistic approach, considering the needs of members, providers, brokers, employees and the broader community.

Metals Mayhem Hits American Manufacturing and Trade Ties

On today’s Big Take DC podcast: The impact Trump’s metals tariffs could have on the US economy and its relationships with some of its closest allies.

Crown Bioscience Appoints John Gu as Chief Executive Officer

Crown Bioscience has appointed John Gu as its new Chief Executive Officer. Following his tenure as interim CEO and his role as chief operating officer, John Gu is recognized as an esteemed leader with broad business acumen and extensive experience in digital strategy, business transformation, and genomic data analysis.

EPAM Systems on LinkedIn
Thank you Pharmaceutical Executive for the amazing feature!

#Leadership #Insights

Cc: Elaina Shekhter Michael Wong

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs